CANNABICS PHARMACEUTICALS (NASDAQOTH:CNBX)

CAPS Rating: 1 out of 5

Caps

How do you think CNBX will perform against the market?

Add Stock to CAPS Watchlist

All Players

5 Outperform
58 Underperform
 

All-Star Players

1 Outperform
44 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top CNBX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Paco57 (46.14)
Submitted February 14, 2017

Like a Fool. I already own 100 shares. I see a USA future investment. And I'm gonna purchase more!

kevday (99.50)
Submitted March 31, 2017

I down thumbed this a while ago, and now, 250% higher (!), I'm taking another look. A lot has changed - this is now an actual company (with seemingly capable management) and actual retail products in the US (slow release THC/CBD pills) through their… More

CNBX VS S&P 500 (SPY)

CNBX Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about CNBX.

Recs

0
Member Avatar kkconway (99.66) Submitted: 9/7/2017 1:53:40 PM : Underperform Start Price: $0.99 CNBX Score: +31.49

WEED HYPE.

Recs

2
Member Avatar kevday (99.50) Submitted: 3/30/2017 8:43:45 PM : Underperform Start Price: $0.82 CNBX Score: +26.03

I down thumbed this a while ago, and now, 250% higher (!), I'm taking another look.

A lot has changed - this is now an actual company (with seemingly capable management) and actual retail products in the US (slow release THC/CBD pills) through their partnership with Wana. They still have some loopy ideas about treating cancer tumors with marijuana extracts. The latest 10-Q however (3 months ended Nov 30, 2016) shows ZERO revenue.

"The Company has incurred a net loss of $147,014 for the three months ended November 30, 2016 and has incurred
cumulative losses since inception of $1,733,333. These conditions raise substantial doubt about the ability of the Company to continue as a going concern."

"...on January 5, 2017, the Company issued 5,055,334 shares to 13 investors at $.09 per share for a total of $449,573. Also on January 5, 2017, the Company issued 1,800,000 shares to 7 individuals who exercised their previous Warrant Rights at $.03 per share for a total of $54,000."

Man, I wish I was one of those investors at $0.09 per share! There were 114MM shares outstanding at the end of the quarter - at $3/share that's a market cap of $350MM for a company with ZERO revenue (and expected to have an immediate need to raise $700k just to continue operations in 2017).

They've assembled a capable team and executed pretty well so far, but I fear they've been using too much of their product and have a wacky sense of how effective it may be in actually treating cancer (not just alleviating symptoms). So I'm still thumbs down on this one!

Recs

0
Member Avatar kdakota630 (29.70) Submitted: 12/30/2016 10:03:29 AM : Underperform Start Price: $0.63 CNBX Score: +2.32

No way.

Leaderboard

Find the members with the highest scoring picks in CNBX.

Score Leader

Under5

Under5 (< 20) Score: +202.28

The Score Leader is the player with the highest score across all their picks in CNBX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
Emeraldo < 20 2/23/2017 Underperform 1Y $4.19 -82.80% +8.54% +91.34 0 Comment
whatisthepoint 96.45 2/17/2017 Underperform 5Y $3.88 -81.44% +9.69% +91.13 0 Comment
km00nster < 20 2/17/2017 Underperform 5Y $3.08 -76.59% +9.90% +86.49 0 Comment
wmtworker 78.44 2/27/2017 Underperform 5Y $3.18 -77.32% +8.65% +85.97 0 Comment
gcaderas 78.94 4/18/2017 Underperform 5Y $2.28 -68.35% +10.01% +78.36 0 Comment
FoolTheRest 99.93 11/9/2016 Underperform 5Y $1.13 -36.28% +20.45% +56.74 0 Comment
PAGEBOY54 95.74 7/18/2017 8/18/2017 Underperform 3Y $1.47 -51.02% +4.77% +55.79 0 Comment
jed71 99.86 11/3/2016 Underperform 5Y $1.07 -32.39% +22.44% +54.83 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. glenn12345 99.95 8/1/2017 Underperform 5Y $1.38 -47.83% +3.98% +51.81 0 Comment
tvance84 68.84 7/28/2017 Underperform 5Y $1.26 -42.86% +4.24% +47.10 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CNBX.

Featured Broker Partners